DRKS00024387已完成不适用
App-based investigation of patient-reported outcomes in TYSABRI therapy - TRAIT
Medizin0 个研究点目标入组 35 人开始时间: 2021年2月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •relapsing remitting multiple sclerosis
排除标准
- •progressve multiple scleroses and patients without a therapy with natalizumab
研究者
相似试验
已完成
不适用
Real-time collection and use of patient-reported outcome measures and patient-reported experience measures in an outpatient oncology settingCancer - Any cancercancerACTRN12619001470189Monash Health493
已完成
Unknown
To check the safety and benefit of Ahaglow Gentle Cleanser for daily use in dry sensitive skiCTRI/2023/06/053708Torrent Pharmaceuticals Ltd,568
尚未招募
Unknown
Assessing patient reported outcome and clinical severity in patients with Oral Lichen PlanusCTRI/2024/01/061185Dr Lakshmi Priya
招募中
Unknown
To evaluate safety and benefit of Ahaglow (GlycOlic acid, Aloe veRa and Vitamin-E) based face wash for daily use in Acne Prone SkiCTRI/2023/06/053763Torrent Pharmaceuticals Ltd,
进行中（未招募）
不适用
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution - DuoTrav APS versus XALACOM® in Patient Reported Outcomes and Ocular Surface HealthEUCTR2009-010604-29-BEAlcon Research, Ltd.400